| CHI SIAMO |  |
| DOVE SIAMO | |
METODO DI BELLA > INDICE DELLA DOCUMENTAZIONE > DOCUMENTAZIONE SCIENTIFICA
DOCUMENTAZIONE SCIENTIFICA
Monitoring intracellular melatonin levels in human prostate normal and cancer cells by HPLC.
(06/05/2011)
Dettaglio
Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines.
(06/05/2011)
Dettaglio
Measuring serum melatonin in epidemiologic studies.
(06/05/2011)
Dettaglio
Inhibitory effects of melatonin on sulfatase and 17beta-hydroxysteroid dehydrogenase activity and expression in glioma cells.
(06/05/2011)
Dettaglio
Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort.
(06/05/2011)
Dettaglio
Beneficial effects of melatonin on nicotine-induced vasculopathy.
(06/05/2011)
Dettaglio
Antioxidant enzymatically modified isoquercitrin or melatonin supplementation reduces oxidative stress-mediated hepatocellular tumor promotion of oxfendazole in rats.
(06/05/2011)
Dettaglio
Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway.
(06/05/2011)
Dettaglio
Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer.
(06/05/2011)
Dettaglio
Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
(06/05/2011)
Dettaglio
Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields.
(06/05/2011)
Dettaglio
The expression of MT1 melatonin receptor and Ki-67 antigen in melanoma malignum.
(06/05/2011)
Dettaglio
MT1 melatonin receptors and their role in the oncostatic action of melatonin
(06/05/2011)
Dettaglio
Actual and potential agents and biomarkers in the treatment of cancer.
(06/05/2011)
Dettaglio
Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
(06/05/2011)
Dettaglio
